两融数据显示，该股最新融资余额为7087.72万元，近5日减少1590.37万元，降幅为18.33%。（数据 宝） 1月8日万德斯大宗交易一览 万德斯1月8日大宗交易平台出现一笔成交，成交量35.00万股，成交金额845.60万元，大宗交易成交价为 24.16元。该笔交易的买方营业部为招商证券股份有限公司福州六一中路证券营业部，卖方营业部为中 国银河证券股份有限公司福州证券营业部。 进一步统计，近3个月内该股累计发生2笔大宗交易，合计成交金额为2980.60万元。 证券时报·数据宝统计显示，万德斯今日收盘价为24.16元，上涨1.34%，日换手率为0.74%，成交额为 1516.43万元，全天主力资金净流出242.02万元，近5日该股累计上涨0.04%，近5日资金合计净流出 651.66万元。 | 成交量 | 成交金额 | 成交价 | 相对当日收盘 | | | | --- | --- | --- | --- | --- | --- | | （万 | （万元） | 格 | 折溢价（%） | 买方营业部 | 卖方营业部 | | 股） | | （元） | | | | | 35.00 | 845.60 | 24.16 ...

1月8日，万德斯大宗交易成交35万股，成交额845.6万元，占当日总成交额的35.8%，成交价24.16元，较市场收盘价24.16元持平。 | 交易日期 | 证券简称 | 证券代码 | 成交价(元) 成交金额(万元) 成交量( * ) 买入营业部 | | 卖出营业部 | | --- | --- | --- | --- | --- | --- | | 2026-01-08 | 万德斯 | 688178 | 24.16 845.6 ਤੇ ਤੇ | 招商证券股份有限 公司福州六一中路 | 中国银河证券股份 有限公司福州证券 | ...

Group 1 - Shenghui Integration (603163.SH): The stock price has risen significantly in the short term, deviating from the company's fundamentals, indicating a potential risk of decline in the future [1] - Victory Energy (001331.SZ): The company does not engage in robotics-related business [1] - Aerospace Engineering (603698.SH): The company does not involve in commercial aerospace [1] Group 2 - Wankai New Materials (301216.SZ): The controlling subsidiary plans to provide lightweight components and structural parts related to humanoid robot arms and humanoid assembly services to Lingxin Qiaoshou [1] - Huakang Clean (301235.SZ): The consortium is pre-awarded the procurement project for special departments of Huian County Hospital (Phase I) [1] - Tongda Co., Ltd. (002560.SZ): Pre-awarded a 154 million yuan project from the State Grid [1] Group 3 - Aier Eye Hospital (300015.SZ): Plans to acquire partial equity in 39 institutions including Bozhou Aier and Lianyungang Aier [1] - Aucma (600336.SH): Plans to transfer 55% equity of the Information Industry Park company [1] - Donghong Co., Ltd. (603856.SH): Plans to repurchase shares with an investment of 30 million to 60 million yuan [1] Group 4 - Caesar Travel (000796.SZ): Jingu Trust plans to reduce its holdings by no more than 3% [1] - Jindun Co., Ltd. (300411.SZ): High-tech Investment and Founder Securities plan to collectively reduce their holdings by no more than 4% [1] - Hengdian East Magnetic (002056.SZ): The controlling shareholder plans to reduce its holdings by no more than 1% [1] Group 5 - Lianchuang Electronics (002036.SZ): Plans to raise no more than 1.63 billion yuan through a private placement to Jiangxi State-owned Capital Venture [1] - Xingyuan Zhuomag (301398.SZ): Received project designation notification from a client [1]

Group 1 - Jizhi Co., Ltd. plans to acquire at least 51% equity in Pumai Technology through cash payment, aiming to gain control over the company, which is a leading enterprise in the field of robot performance testing and calibration in China [1] - Yaxing Chemical's subsidiary intends to transfer 7.14% equity for 60 million yuan to another fund under the same control, indicating strategic investment movements within the same management group [2] - Weigao Bio's application for clinical trials of subcutaneous human immunoglobulin has been accepted by the National Medical Products Administration, targeting primary immunodeficiency diseases [3] Group 2 - Sentai Co., Ltd.'s controlling shareholder plans to increase shareholding by at least 100 million yuan within 12 months, aiming to enhance confidence in the company's future [4] - Health元's subsidiary has received acceptance for the marketing authorization application of Lecanemab injection, which is intended for moderate to severe plaque psoriasis patients [5][11] - Sunshine Nuohuo has signed a technical development contract for the STC008 injection project, with a total payment of 500 million yuan, indicating significant investment in cancer treatment [6] Group 3 - Hunan YN has been designated as a delivery warehouse for lithium carbonate by the Guangzhou Futures Exchange, enhancing its position in the lithium market [7] - Tianji Co., Ltd. is pushing for the industrialization of lithium sulfide material preparation, although it faces risks in commercialization [8] - Yuandong Bio has received FDA approval for Methylene Blue injection, expanding its product portfolio in the U.S. market [10] Group 4 - Nanshan Aluminum has established a wholly-owned subsidiary in Hainan with an investment of 5 million yuan, focusing on high-end aluminum products [13] - ST Xifa plans to acquire 50% equity in Lhasa Beer, aiming for full ownership, with the transaction currently in the planning stage [14] - Hengrui Medicine's SHR-A1904 injection has been included in the list of breakthrough therapy products, indicating its potential in treating advanced gastric cancer [12] Group 5 - Chengdu Gas is planning to merge three subsidiaries, streamlining operations and enhancing efficiency [26] - Baoli Electric intends to invest 50 million yuan to establish a wholly-owned subsidiary focused on key equipment and solutions in energy storage [27] - Huadian International has successfully put the second unit of its Longkou Phase IV project into commercial operation, marking a significant milestone in its energy production capacity [34]

证券代码：688178 证券简称：万德斯 公告编号：2025-045 南京万德斯环保科技股份有限公司 关于自愿披露中标芜湖市天门山污水处理厂 三期扩建工程特许经营项目的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 中标项目：芜湖市天门山污水处理厂三期扩建工程特许经营项目（以下 简称"本项目"） 投资金额：约 37,963.38 万元； 项目运作机制：本项目采用 BOT（建设-运营-移交）的特许经营模式； 特许经营期限：40 年。其中建设期限：拟定不超过 12 个月（自合同签订 日起至项目环保验收通过之日止）；运营期限：自项目环保验收通过次 日起至项目移交日止； 风险提示：公司目前已收到此次招标的中标通知书，但尚未与招标人签 订相关正式合同，合同签署时间及履约安排存在不确定性。本项目所涉 最终金额、履行条款等内容以正式签订的合同为准。本项目尚未正式投 产运营，污水处理服务费与污水处理量存在不确定性，且本项目跨年分 期实施、提供服务等，公司将会分期对项目收入进行确认，因此对 2025 年当期和以后期间业 ...

格隆汇12月24日丨万德斯(688178.SH)公布，公司收到招标人芜湖经济技术开发区建设和公用事业管理 处签发的《中标通知书》，通知公司为芜湖市天门山污水处理厂三期扩建工程特许经营项目中标单位， 投资金额约3.8亿元。 ...

格隆汇12月24日｜万德斯(688178.SH)公告称，公司收到招标人芜湖经济技术开发区建设和公用事业管 理处签发的《中标通知书》，成为芜湖市天门山污水处理厂三期扩建工程特许经营项目的中标单位，投 资金额约3.7963亿元。项目采用BOT模式，特许经营期限40年，建设期限不超过12个月。公司目前已收 到中标通知书，但尚未签订正式合同，合同签署时间及履约安排存在不确定性。本项目尚未正式投产运 营，污水处理服务费与污水处理量存在不确定性，对2025年当期和以后期间业绩影响具有不确定性。 ...

截至目前合同尚未签订，如项目签订正式合同并顺利实施，在项目执行期间将会对公司业务发展及经营 业绩产生积极的影响。 智通财经APP讯，万德斯(688178.SH)发布公告，近日，公司收到招标人芜湖经济技术开发区建设和公 用事业管理处签发的《中标通知书》，通知公司为芜湖市天门山污水处理厂三期扩建工程特许经营项目 中标单位，投资金额约3.8亿元。该项目采用BOT(建设-运营-移交)的特许经营模式，特许经营期限40 年。 ...

人民财讯12月24日电，万德斯(688178)12月24日公告，公司中标芜湖市天门山污水处理厂三期扩建工程 特许经营项目，投资金额约3.8亿元，项目采用BOT(建设-运营-移交)的特许经营模式，特许经营期限40 年，其中建设期限拟定不超过12个月。 ...

万德斯(688178.SH)发布公告，近日，公司收到招标人芜湖经济技术开发区建设和公用事业管理处签发 的《中标通知书》，通知公司为芜湖市天门山污水处理厂三期扩建工程特许经营项目中标单位，投资金 额约3.8亿元。该项目采用BOT(建设-运营-移交)的特许经营模式，特许经营期限40年。 截至目前合同尚未签订，如项目签订正式合同并顺利实施，在项目执行期间将会对公司业务发展及经营 业绩产生积极的影响。 ...